Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Breast Cancer Prognostic Factor"'
Publikováno v:
JAMA Network Open
This prognostic study identifies independent clinical and molecular measurements associated with overall and recurrence-free survival by homogeneous treatment in patients with breast cancer.
Key Points Question Is the performance of clinical and
Key Points Question Is the performance of clinical and
Publikováno v:
International Journal of Surgery and Medicine, Vol 2, Iss 1, Pp 23-29 (2016)
Background: Axillary lymph node status is the most important breast cancer prognostic factor. Preoperative axillary ultrasound examination (PAUS) is used to triage patients for sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND
Autor:
Pauline T. Truong, Betro T. Sadek, Mina N. Shenouda, David John Peterson, Alphonse G. Taghian, Rita Abi Raad, Cheryl Alexander, Bradley Wiksyk
Publikováno v:
Annals of Surgical Oncology. 21:3490-3496
While human epidermal growth factor receptor 2 (HER2) overexpression is an adverse breast cancer prognostic factor, it is unclear whether there are differences in outcomes between types of local treatment in this population. This retrospective study
Publikováno v:
Annals of Oncology. 30:v77
Background Some registry-based and population-based studies have suggested that high parity could be an adverse prognostic factor in luminal breast cancer, although the definition of breast cancer subtypes has been varied and prospective studies are
Autor:
Loki Natarajan, Ruth E. Patterson, Shirley W. Flatt, Sandahl H Nelson, Catherine R. Marinac, Caitlin I. Breen, Sheri J. Hartman, John P. Pierce, Dorothy D. Sears
Publikováno v:
Marinac, CR; Nelson, SH; Breen, CI; Hartman, SJ; Natarajan, L; Pierce, JP; et al.(2016). Prolonged Nightly Fasting and Breast Cancer Prognosis. JAMA ONCOLOGY, 2(8), 1049-1055. doi: 10.1001/jamaoncol.2016.0164. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/1vj6m5f2
JAMA oncology, vol 2, iss 8
JAMA oncology, vol 2, iss 8
Importance Rodent studies demonstrate that prolonged fasting during the sleep phase positively influences carcinogenesis and metabolic processes that are putatively associated with risk and prognosis of breast cancer. To our knowledge, no studies in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a7da7869648382d44f1586e2cd6dc60
http://www.escholarship.org/uc/item/1vj6m5f2
http://www.escholarship.org/uc/item/1vj6m5f2
Autor:
Maria Rita Dionísio, Manuela Lacerda, Joana Paredes, Madalena Gomes, André Filipe Vieira, Fernando Schmitt, Jorge F Cameselle-Teijeiro, Isabel Amendoeira
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 30(5)
Axillary lymph node metastases represent the most powerful breast cancer prognostic factor, dictating disease staging and clinical therapeutic decisions. Nonetheless, breast cancer patients with positive lymph nodes still exhibit a heterogeneous beha
Publikováno v:
JAMA oncology. 2(10)
Importance The presence of tumor-infiltrating lymphocytes (TILs) is a favorable prognostic factor in breast cancer, and TILs may synergize with chemotherapy and immune checkpoint inhibitor therapy for improved clinical response. A more detailed under
Autor:
Mariana Chavez-MacGregor, Jose Vila, Aysegul A. Sahin, W. Fraser Symmans, Gabriel N. Hortobagyi, Elizabeth A. Mittendorf, Susan L. Tucker, Benjamin Smith, Kelly K. Hunt
Publikováno v:
JAMA oncology. 2(7)
Importance We previously described and validated a breast cancer staging system (CPS+EG, clinical-pathologic scoring system incorporating estrogen receptor–negative disease and nuclear grade 3 tumor pathology) for assessing prognosis after neoadjuv